About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial

April 17, 2015

click here to read more

Post navigation

Phosphagenics Appoints Three New Directors

Appendix 3X Notices – Three New Directors

Related Posts

Phosphagenics Market Update

September 1, 2017

Phosphagenics Featured on The RedChip Money Report Airing on Bloomberg

April 8, 2016

AGM Chairman’s Address and CEO Presentation

May 28, 2018

Recent Posts

New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.